Institute for Experimental Pathology, Center for Molecular Biology of Inflammation, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Cell Mol Immunol. 2022 Feb;19(2):177-191. doi: 10.1038/s41423-021-00832-3. Epub 2022 Jan 17.
Chronic inflammation is a component of many disease conditions that affect a large group of individuals worldwide. Chronic inflammation is characterized by persistent, low-grade inflammation and is increased in the aging population. Neutrophils are normally the first responders to acute inflammation and contribute to the resolution of inflammation. However, in chronic inflammation, the role of neutrophils is less well understood and has been described as either beneficial or detrimental, causing tissue damage and enhancing the immune response. Emerging evidence suggests that neutrophils are important players in several chronic diseases, such as atherosclerosis, diabetes mellitus, nonalcoholic fatty liver disease and autoimmune disorders. This review will highlight the interaction of neutrophils with other cells in the context of chronic inflammation, the contribution of neutrophils to selected chronic inflammatory diseases, and possible future therapeutic strategies.
慢性炎症是影响全球大量人群的许多疾病状态的一个组成部分。慢性炎症的特征是持续的低度炎症,并在老年人群中增加。中性粒细胞通常是急性炎症的第一反应者,并有助于炎症的消退。然而,在慢性炎症中,中性粒细胞的作用尚不清楚,被描述为有益或有害,导致组织损伤和增强免疫反应。新出现的证据表明,中性粒细胞在几种慢性疾病中起着重要作用,如动脉粥样硬化、糖尿病、非酒精性脂肪性肝病和自身免疫性疾病。本综述将重点介绍中性粒细胞在慢性炎症背景下与其他细胞的相互作用、中性粒细胞对某些慢性炎症性疾病的贡献,以及可能的未来治疗策略。